Peterman T A
Centers for Diseases Control and Prevention, Atlanta, USA.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2002 Mar;45(3):286-90. doi: 10.1007/s00103-001-0368-x.
There is great interest in the development of surrogate measures for HIV infection that could be used in intervention trials. The sample size needed to detect a change in HIV incidence may be 10 times larger than the sample needed to detect a change in STD (sexually transmitted disease) incidence, and 200 times larger than that needed to detect a change in behavior. We do not know how accurately we can measure sexual behavior. We know many factors that influence responses to questions. Although behavior is clearly associated with STD and HIV, acquisition of disease requires sexual contact with an infected person. Questionnaires have been unable to satisfactorily measure the prevalence of infection in a person's partners. Behavior is not a good surrogate for STD or HIV because behavior change interventions can change question answering behavior, and people have safe sex with risky partners and risky sex with safe partners. STD are not a good surrogate for HIV if the intervention influences STD treatment, if protective behaviors such as condom use influence some STD more than others, or if HIV specific interventions are used, such as deciding to have sex without a condom if a partner has a negative HIV test.
人们对开发可用于干预试验的艾滋病毒感染替代指标非常感兴趣。检测艾滋病毒发病率变化所需的样本量可能比检测性传播疾病(STD)发病率变化所需的样本量多10倍,比检测行为变化所需的样本量多200倍。我们不知道我们能多准确地测量性行为。我们知道许多影响对问题回答的因素。虽然行为显然与性传播疾病和艾滋病毒有关,但感染疾病需要与感染者进行性接触。问卷调查无法令人满意地测量一个人伴侣中的感染率。行为不是性传播疾病或艾滋病毒的良好替代指标,因为行为改变干预措施可以改变问题回答行为,而且人们会与高危伴侣进行安全性行为,与低危伴侣进行危险性行为。如果干预措施影响性传播疾病的治疗,如果诸如使用避孕套等保护行为对某些性传播疾病的影响大于其他疾病,或者如果使用了艾滋病毒特异性干预措施,例如如果伴侣的艾滋病毒检测呈阴性就决定不使用避孕套进行性行为,那么性传播疾病就不是艾滋病毒的良好替代指标。